Drug Resistance, Viral
Showing 1 - 25 of >10,000
HIV/AIDS Trial in Masaka (Intensive Adherence Counselling (IAC))
Not yet recruiting
- HIV/AIDS
- Intensive Adherence Counselling (IAC)
-
Masaka, UgandaKalisizo Hospital
Aug 22, 2022
HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)
Recruiting
- HIV-1-infection
- Multi-Antiviral Resistance
- REGISTER CREATION
-
Milan, MI, ItalyOspedale San Raffaele
Dec 22, 2021
Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction
Not yet recruiting
- Hiv
- +5 more
- differences in CD4 reconstruction
- (no location specified)
Sep 17, 2023
Distinguishing Bacterial and Viral Infections by MeMed BV® Test
Recruiting
- Viral Infection
- +3 more
- MeMed BV®
-
Attiki, Chaidari, Greece
- +1 more
Jun 1, 2023
Virus Infection, RNA Trial in Los Angeles (GenX intergenerational mentoring program)
Not yet recruiting
- Virus Infection, RNA
- GenX intergenerational mentoring program
-
Los Angeles, CaliforniaUCLA School of Medicine
Sep 6, 2022
Viral Resistance, Treatment Failure Trial in Eldoret (Electronic Dose Monitoring (MEMS))
Completed
- Viral Resistance
- Treatment Failure
- Electronic Dose Monitoring (MEMS)
-
Eldoret, KenyaMoi Teaching and Referral Hospital - AMPATH Center
Jul 20, 2020
Multiple Myeloma Trial in Roma, Rome (ChIP-seq, NGS, ATAC-seq)
Recruiting
- Multiple Myeloma
- ChIP-seq, NGS, ATAC-seq
-
Roma, Italy
- +1 more
May 24, 2023
AMR-DetecTool for the Diagnostic of MDR Bacterial Infections
Completed
- Bacterial Sensitivity Tests
- Antimicrobial Drug Resistance
- AMR LFIA Assay
-
Le Kremlin-Bicêtre, France
- +2 more
Jan 12, 2023
HIV/AIDS Trial in Elandsdoorn (Intensified monitoring, Standard of care monitoring)
Completed
- HIV/AIDS
- Intensified monitoring
- Standard of care monitoring
-
Elandsdoorn, Limpopo, South AfricaNdlovu Medical Centre
May 10, 2022
Virologic Failure and Drug Resistance at and After Switching to
Active, not recruiting
- Hiv
- +2 more
-
Lilongwe, Malawi
- +1 more
Feb 14, 2022
Carbapenem-Resistant Enterobacteriaceae Infection Trial in Jinan (CAZ/AVI plus Aztreonam, Conventional treatment)
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- CAZ/AVI plus Aztreonam
- Conventional treatment
-
Jinan, Shandong, ChinaMingju Hao
Apr 29, 2023
Large Scale Transition toDolutegravir-based First-line ART in
Not yet recruiting
- HIV Infections
-
Abidjan, Côte D'Ivoire
- +2 more
Mar 28, 2022
Antimicrobial Resistance in Hospitals From Meta, Colombia
Not yet recruiting
- Increased Drug Resistance
- Factors associated
-
Villavicencio, Meta, ColombiaHospital Departamental de Villavicencio
Sep 16, 2023
Performance Study of Targeted Sequencing Technology for VAP
Not yet recruiting
- VAP - Ventilator Associated Pneumonia
- tNGS
- (no location specified)
Sep 6, 2023
Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)
Not yet recruiting
- Ovarian Cancer
- Decitabine
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Aug 1, 2023
Drug Resistance, Bacterial, Antimicrobial Drug Resistance Trial in Gdansk, Kielce, Warszawa (Fecal Microbiota Transplantation)
Recruiting
- Drug Resistance, Bacterial
- Antimicrobial Drug Resistance
- Fecal Microbiota Transplantation
-
Gdańsk, Poland
- +4 more
Dec 1, 2023
Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)
Recruiting
- Healthy Adults
- Adagrasib
- Eltrombopag + adagrasib
-
Daytona Beach, FloridaFortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
Jun 29, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Bile Acids in Acute Insulin Resistance
Recruiting
- PI3K Gene Mutation
- +4 more
- Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
-
New York, New YorkColumbia University Medical Center
Oct 6, 2022
Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))
Recruiting
- Hepatitis C
- +2 more
- Sofosbuvir/velpatasvir (Epclusa®)
-
Hazard, KentuckyARH Medical Mall
Sep 25, 2022
Psychiatric Disorder, Drug Use Trial in Haiphong (Community-based psychiatric intervention)
Recruiting
- Psychiatric Disorder
- Drug Use
- Community-based psychiatric intervention
-
Haiphong, Hai Phong, VietnamMental Health Department
May 23, 2023
Plasmodium Falciparum Antimalarial Drug Resistance Markers
Completed
- Plasmodium Falciparum
-
Kome, Doba, ChadStudy clinic
Mar 29, 2022
Study of the Use of the Drug Ingaron in Patients With COVID-19
Completed
- COVID-19 Respiratory Infection
- Viral Pneumonia
- Interferon Gamma
-
Moscow, Russian FederationCity Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 23, 2022